Tumor cells growth and survival time with the ketogenic diet in animal models: A systematic review

International Journal of Preventive Medicine

Volumn 8, Issue , 2017, Pages

  Khodadadi, Soheila ^a,b   Sobhani, Nafiseh ^a,b   Mirshekar, Somaye ^a,b   Ghiasvand, Reza ^a,b   Pourmasoumi, Makan ^a,b   Miraghajani, Maryam ^c   Dehsoukhteh, Somayeh Shahraki ^d  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF ZABOL   (Iran)

Author keywords

Cancer; Ketogenic diet; Survival; Tumor growth

Indexed keywords

BRAIN TUMOR; CANCER INHIBITION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; COLON TUMOR; KETOGENIC DIET; LUNG CANCER; NEUROBLASTOMA; NONHUMAN; PANCREAS TUMOR; PROSTATE TUMOR; REVIEW; STOMACH TUMOR; SURVIVAL TIME; TUMOR CELL; TUMOR GROWTH;

EID: 85020801121     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: 10.4103/2008-7802.207035     Document Type: Review

References (45)

1. Rafie N, Golpour Hamedani S, Ghiasvand R, Miraghajani M.: Kefir and cancer: A systematic review of literatures. Arch Iran Med 2015;18:852-7.
2. Farsinejad-Marj M, Talebi S, Ghiyasvand R, Miraghajani M. Adherence to Mediterranean diet and risk of breast cancer in premenopausal and postmenopausal women. Arch Iran Med 2015;18:786-92.
3. Golpour S, Rafie N, Safavi SM, Miraghajani M.: Dietary isoflavones and gastric cancer: A brief review of current studies. J Res Med Sci 2015;20:893-900.
4. Jolfaie NR, Mirzaie S, Ghiasvand R, Askari G, Miraghajani M. The effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic review. J Res Med Sci 2015;20:910-8.
5. Freeman JM, Kossoff EH.: Ketosis and the ketogenic diet, 2010: Advances in treating epilepsy and other disorders. Adv Pediatr 2010;57:315-29.
6. Sharma S, Jain P. The ketogenic diet and other dietary treatments for refractory epilepsy in children. Ann Indian Acad Neurol 2014;17:253-8.
7. Streijger F, Plunet WT, Lee JH, Liu J, Lam CK, Park S, et al. Ketogenic diet improves forelimb motor function after spinal cord injury in rodents. PLoS One 2013;8:e78765.
8. Paoli A, Bianco A, Damiani E, Bosco G. Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res Int 2014;2014:474296.
9. Poff AM, Ari C, Seyfried TN, D’Agostino DP. The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One 2013;8:e65522.
10. Allen BG, Bhatia SK, Buatti JM, Brandt KE, Lindholm KE, Button AM, et al. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clin Cancer Res 2013;19:3905-13.
11. Tisdale MJ, Brennan RA, Fearon KC. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer 1987;56:39-43.
12. Otto C, Kaemmerer U, Illert B, Muehling B, Pfetzer N, Wittig R, et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer 2008;8:122.
13. Klement RJ. Restricting carbohydrates to fight head and neck cancer-is this realistic? Cancer Biol Med 2014;11:145-61.
14. Klement RJ. Calorie or carbohydrate restriction? The ketogenic diet as another option for supportive cancer treatment. Oncologist 2013;18:1056.
15. Kim HS, Masko EM, Poulton SL, Kennedy KM, Pizzo SV, Dewhirst MW, et al. Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer. BJU Int 2012;110:1062-9.
16. Masko EM, Thomas JA II, Antonelli JA, Lloyd JC, Phillips TE, Poulton SH, et al. Low-carbohydrate diets and prostate cancer: How low is “low enough”? Cancer Prev Res (Phila) 2010;3:1124-31.
17. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol 2014;14:43.
18. Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond) 2007;4:5.
19. Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, et al. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One 2012;7:e36197.
20. Mavropoulos JC, Buschemeyer WC II, Tewari AK, Rokhfeld D, Pollak M, Zhao Y, et al. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. Cancer Prev Res (Phila) 2009;2:557-65.
21. Morscher RJ, Aminzadeh-Gohari S, Feichtinger RG, Mayr JA, Lang R, Neureiter D, et al. Inhibition of neuroblastoma tumor growth by ketogenic diet and/or calorie restriction in a CD1-Nu mouse model. PLoS One 2015;10:e0129802.
22. Hao GW, Chen YS, He DM, Wang HY, Wu GH, Zhang B. Growth of human colon cancer cells in nude mice is delayed by ketogenic diet with or without omega-3 fatty acids and medium-chain triglycerides. Asian Pac J Cancer Prev 2015;16:2061-8.
23. Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br J Cancer 2003;89:1375-82.
24. Shukla SK, Gebregiworgis T, Purohit V, Chaika NV, Gunda V, Radhakrishnan P, et al. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab 2014;2:18.
25. Caso J, Masko EM, Ii JA, Poulton SH, Dewhirst M, Pizzo SV, et al. The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model. Prostate 2013;73:449-54.
26. Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab 2007;4:1.
27. Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria of published animal studies: A systematic review. Environ Health Perspect 2013;121:985-92.
28. Allen BG, Bhatia SK, Anderson CM, Eichenberger-Gilmore JM, Sibenaller ZA, Mapuskar KA, et al. Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biol 2014;2:963-70.
29. Maroon JC, Seyfried TN, Donohue JP, Bost J. The role of metabolic therapy in treating glioblastoma multiforme. Surg Neurol Int 2015;6:61.
30. Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Metabolic management of brain cancer. Biochim Biophys Acta 2011;1807:577-94.
31. Liang BC, Grootveld M. The importance of mitochondria in the tumourigenic phenotype: Gliomas as the paradigm (review). Int J Mol Med 2011;27:159-71.
32. Maroon J, Bost J, Amos A, Zuccoli G. Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme. J Child Neurol 2013;28:1002-8.
33. Seyfried TN, Shelton LM, Mukherjee P. Does the existing standard of care increase glioblastoma energy metabolism? Lancet Oncol 2010;11:811-3.
34. Robey RB, Hay N. Is Akt the “Warburg kinase”? – Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 2009;19:25-31.
35. McDaniel SS, Rensing NR, Thio LL, Yamada KA, Wong M. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia 2011;52:e7-11.
36. Woolf EC, Stafford P, Abdelwahab MG, Fenton K, Preul MC, Scheck AC. The ketogenic diet potentiates radiation therapy in a mouse model of glioma: Effects on inflammatory pathways and reactive oxygen species. Cancer Res 2013;73 8 Suppl: 4441.
37. Stafford P, Abdelwahab MG, Kim DY, Preul MC, Rho JM, Scheck AC. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond) 2010;7:74.
38. Dupuis N, Curatolo N, Benoist JF, Auvin S. Ketogenic diet exhibits anti-inflammatory properties. Epilepsia 2015;56:e95-8.
39. Ruskin DN, Kawamura M, Masino SA. Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS One 2009;4:e8349.
40. Kim DY, Hao J, Liu R, Turner G, Shi FD, Rho JM. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One 2012;7:e35476.
41. Kang HC, Chung DE, Kim DW, Kim HD. Early-and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004;45:1116-23.
42. Paoli A, Moro T, Bosco G, Bianco A, Grimaldi KA, Camporesi E, et al. Effects of n-3 polyunsaturated fatty acids (ω-3) supplementation on some cardiovascular risk factors with a ketogenic Mediterranean diet. Mar Drugs 2015;13:996-1009.
43. Moriyama K, Watanabe M, Yamada Y, Shiihara T. Protein-losing enteropathy as a rare complication of the ketogenic diet. Pediatr Neurol 2015;52:526-8.
44. Hawkes CP, Levine MA.: Ketotic hypercalcemia: A case series and description of a novel entity. J Clin Endocrinol Metab 2014;99:1531-6.
45. Bozzetti F, Zupec-Kania B. Toward a cancer-specific diet. Clin Nutr 2016;35:1188-95.